Mark Hancock sells 438,069 PACS shares across June 2026 (PACS)

Rhea-AI Filing Summary

Mark Hancock sold Common stock reported on a Form 144. The filing lists multiple open-market dispositions: 153,254 shares on 06/15/2026 for $5,568,759.95, 63,680 shares on 06/17/2026 for $2,248,413.44, 83,066 shares on 06/16/2026 for $2,982,385.05, and 138,069 shares on 06/25/2026 for $5,567,701.46.

The record also shows 54,626,199 shares were "acquired at formation of the issuer" on 03/01/2023. The transactions are presented as sales with gross proceeds shown next to each trade date.

Insights

Securities Compliance Analyst

Form 144 discloses multiple share dispositions by a single reporting person.

The filing lists four separate sales by Mark Hancock across 06/15/2026–06/25/2026, with individual trade sizes from 63,680 to 153,254 shares and proceeds shown in dollars. The document also records 54,626,199 shares "acquired at formation" on 03/01/2023, which appears as an historic ownership entry.

Review compliance with Rule 144 timing and volume limits if applicable; filings like this typically document completed dispositions and provide traceability. Subsequent public filings may clarify whether these sales were part of an orderly plan or one-off transactions.

Key Figures

Total shares sold (sum of listed trades): 438,069 shares Proceeds from 06/15/2026 sale: $5,568,759.95 Proceeds from 06/16/2026 sale: $2,982,385.05 +3 more

6 metrics

Total shares sold (sum of listed trades) 438,069 shares Aggregate of 153,254; 63,680; 83,066; 138,069 on June 2026 dates

Proceeds from 06/15/2026 sale $5,568,759.95 153,254 shares sold on <date>06/15/2026</date>

Proceeds from 06/16/2026 sale $2,982,385.05 83,066 shares sold on <date>06/16/2026</date>

Proceeds from 06/17/2026 sale $2,248,413.44 63,680 shares sold on <date>06/17/2026</date>

Proceeds from 06/25/2026 sale $5,567,701.46 138,069 shares sold on <date>06/25/2026</date>

Shares acquired at formation 54,626,199 shares Acquired at formation of the issuer on <date>03/01/2023</date>

Key Terms

Form 144, acquired at formation of the issuer, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

acquired at formation of the issuer market

"shares acquired at formation of the issuer"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/26/2026 - 02:22 PM Accepted by SEC EDGAR 06/26/2026 - 02:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	61931	2508081.64	15827237	06/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	shares acquired at formation of the issuer	issuer			54626199	03/01/2023	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/15/2026	153254	5568759.95
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/16/2026	83066	2982385.05
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/25/2026	138069	5567701.46
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/17/2026	63680	2248413.44

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales does the PACS Form 144 report for Mark Hancock?

The Form 144 reports four sales totaling 438,069 shares across June 2026 dates. It lists individual trades: 153,254; 63,680; 83,066; and 138,069 shares with corresponding dollar proceeds next to each date.

How much cash is shown from the reported PACS dispositions?

The filing shows gross proceeds for each trade: $5,568,759.95, $2,248,413.44, $2,982,385.05, and $5,567,701.46. The amounts are presented per sale date in the Form 144 excerpt.

Does the filing show Mark Hancock's total holdings for PACS?

The excerpt records 54,626,199 shares as "acquired at formation of the issuer" on 03/01/2023. The filing does not provide a consolidated post-transaction position in the provided excerpt.

Are the PACS trades dated in the filing and where were they executed?

Yes; trade dates shown are 06/15/2026, 06/16/2026, 06/17/2026, and 06/25/2026. The excerpt does not specify the executing broker or exchange venue.

Was any acquisition method disclosed for the large share block on 03/01/2023?

The filing states those shares were "acquired at formation of the issuer" on 03/01/2023. No additional consideration or terms for that formation acquisition are provided in the excerpt.